Literature DB >> 9015080

Brain tumors: detection with C-11 choline PET.

N Shinoura1, M Nishijima, T Hara, T Haisa, H Yamamoto, K Fujii, I Mitsui, N Kosaka, T Kondo, T Hara.   

Abstract

PURPOSE: To evaluate the effectiveness of positron emission tomography (PET) with carbon-11 choline in brain tumor imaging.
MATERIALS AND METHODS: A rat glioma cell line (C6) was incubated with C-14 choline; the time course of uptake and metabolism was determined in vitro. C-11 choline was injected intravenously in tumor-bearing rats; the time course of distribution in organs was determined. C-11 choline also was injected intravenously in 20 patients (aged 6-86 years) with brain tumors and two volunteers (aged 38 and 58 years); distribution of the tracer in the brain was determined. Regional cerebral blood flow was measured by using oxygen-15 water on the same day.
RESULTS: C-14 choline was metabolized to phosphoryl choline in glioma cells. The uptake of C-11 choline by glioblastoma cells was three to four times higher than that in the rat brain. All brain tumors took up more C-11 choline than did normal brain; thus, brain tumors that were not treated, as well as those that were treated with surgery or radiation therapy, were depicted. The tumor-normal brain uptake ratio of C-11 choline in brain tumor did not correlate with the O-15 water regional blood flow in the corresponding area.
CONCLUSION: C-11 choline PET can depict brain tumors effectively. This method was clinically useful in patients who had undergone surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015080     DOI: 10.1148/radiology.202.2.9015080

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Usefulness of Choline-PET for the detection of residual hemangiopericytoma in the skull base: comparison with FDG-PET.

Authors:  Shin Ito; Junkichi Yokoyama; Hitoshi Yoshimoto; Masaki Yazawa; Kubota Kazuo; Makoto Hanaguri; Shinichi Ohba; Mitsuhisa Fujimaki; Katsuhisa Ikeda
Journal:  Head Face Med       Date:  2012-02-07       Impact factor: 2.151

Review 3.  PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.

Authors:  Giampiero Giovacchini; Elisabetta Giovannini; Rossella Leoncini; Mattia Riondato; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

4.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 5.  Brain tumors.

Authors:  Karl Herholz; Karl-Josef Langen; Christiaan Schiepers; James M Mountz
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

Review 6.  Molecular imaging of brain tumors with radiolabeled choline PET.

Authors:  Ferdinando Franco Calabria; Manlio Barbarisi; Vincenzo Gangemi; Giovanni Grillea; Giuseppe Lucio Cascini
Journal:  Neurosurg Rev       Date:  2016-05-26       Impact factor: 3.042

7.  Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.

Authors:  Takako Yamaguchi; Jin Lee; Hiroji Uemura; Takeshi Sasaki; Nobukazu Takahashi; Takashi Oka; Kazuya Shizukuishi; Hisashi Endou; Yoshinobu Kubota; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-15       Impact factor: 9.236

8.  Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.

Authors:  Nicolas Spaeth; Matthias T Wyss; Jens Pahnke; Gregoire Biollaz; Amelie Lutz; Kerstin Goepfert; Gerrit Westera; Valerie Treyer; Bruno Weber; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-15       Impact factor: 9.236

9.  Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

Authors:  M Utriainen; M Komu; V Vuorinen; P Lehikoinen; P Sonninen; T Kurki; T Utriainen; A Roivainen; H Kalimo; H Minn
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study.

Authors:  Ettore Pelosi; Cristina Messa; Sandro Sironi; Maria Picchio; Claudio Landoni; Valentino Bettinardi; Luigi Gianolli; Alessandro Del Maschio; Maria Carla Gilardi; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.